Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway

Osteosarcoma is the frequent pediatric bone cancer where pediatric osteosarcoma incidences are more than 10% within the population. Most of the patients with osteosarcoma fall within the age of 15–30 years. Therefore, in this research, we examined the anticancer effect of Rhaponticin against the hum...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Saudi J Biol Sci
Main Authors: Mickymaray, Suresh, Alfaiz, Faiz Abdulaziz, Paramasivam, Anand, Veeraraghavan, Vishnu Priya, Periadurai, Nanthini Devi, Surapaneni, Krishna Mohan, Niu, Guangfeng
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8241634/
https://ncbi.nlm.nih.gov/pubmed/34220214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjbs.2021.05.006
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares